Nike Falls 6% on Dwindling Sales and Profits in Q1 With Weak Guidance for Q2: Is it Time to Sell NKE?
Nike Inc. (NKE) is down roughly 6% Wednesday morning after the company’s earnings day Tuesday left much to be desired in the eyes of investors. The company is still struggling to regain its footing, and after withdrawing its full-year guidance, it’s clear that the road ahead will continue to be rocky. Here’s how the footwear brand performed in the [...]
Stellantis Shares Fall Amidst Forecast Cuts: While it May Be Time for Investors to Sell STLA
Shares of Stellantis NV (STLA) are down 11% in the past week as the Netherlands-based automaker was forced to lower its full-year forecast as costs are climbing while production is falling. The company was originally expecting to deliver a double-digit profit percentage for the fiscal year, but now, the profit guidance has been brought down to just 5.5% to [...]
Bristol Myer Stock Gets a Bump on FDA Approval for Schizophrenia Drug: Is it Time to Buy BMY?
Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug. The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious tear over the past few [...]
Weekly Market Recap: Major Indices Manage Gains Amid Economic Data Releases
Monday: The Major Indices started the week in positive territory with investors keeping an eye on the upcoming Personal Consumption Expenditures report. The Dow rose 0.2%, the S&P 500 gained 0.3%, and the Nasdaq added 0.1%. Tuesday: China's new stimulus plan helped boost sentiment despite lower-than-expected housing data, leading to another day of gains. The Dow increased 0.2%, the [...]
Investors’ Inspiration
Written by: Angela Akers In last week’s “Special Presentation,” Mr. Steve Chappell discussed and demonstrated the efficacy and effectiveness of the VectorVest RealTime Derby. The Derby analyzes, sorts, ranks and graphs the second-by-second performance of 169 portfolios. It tracks each portfolio’s performance from the current day’s opening bell and displays the results from the previous day’s close or the [...]
Accenture Gains Nearly 6% on Rising Demand for AI Solutions: 2 Other Reasons It’s Time to Buy ACN
Shares of Accenture (ACN) are up just under 6% in the past week amidst hype for the company’s AI-powered performance in the fourth quarter. The business management consultant posted adjusted earnings per share of $2.79, which matched the analyst consensus. Revenue of $16.41 billion was a 2.6% improvement year over year and ahead of the estimate for just $16.39 [...]
